← All stocks

Sunshine Biopharma Inc.

SBFM Net buying
CIK 0001402328 #5475 in the set updated 21 Sep 2026
Bought (120 mo)
$65.41K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$65.41K
+$65.41K against sales at will

By person

5 insiders · 4 transactions
58.1×

Dr. Steve N. Slilaty holds 58.1 times base salary in stock. $23.92M of shares against $411.59K in salary for 2024.

Salary from the company's own proxy. The shares are what Dr. Steve N. Slilaty last reported holding, valued at $0.10, the price Series B Preferred Stock was last bought or sold at on the open market here, on 4 Mar 2024.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sebaaly Camille
CFO/Secretary
$53.41K (2)
+$53.41K
129,643,392
$12.96M
Slilaty Steve N.
Chief Executive Officer
$12.00K (2)
+$12.00K
239,218,894
$23.92M
+1.5%
Advanomics Corp entity
10% owner
215,014,224
$21.50M
−38.9%
MERZOUKI ABDERRAZZAK
Chief Operating Officer
23,346,168
$2.33M
NATAN DAVID
Director
68,300
$6.83K

No percentages here. This company's share count has moved by a factor of 2.5 over the window, from 1,999,660 to 4,905,945 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Slilaty Steve N.
4 Mar 2024
Chief Executive Officer
Buy
100,000
$0.10
$10.00K
Slilaty Steve N.
8 Feb 2024
Chief Executive Officer
Buy
20,000
$0.10
$2.00K
Sebaaly Camille
30 Nov 2022
CFO/Secretary
Buy
30,000
$0.76
$22.91K
Sebaaly Camille
3 Jun 2022
CFO/Secretary
Buy
25,000
$1.22
$30.50K

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 838,238,509
History held since 7 Nov 2016